Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Fixed Capital/Sales(x) 0.450.450.440.470.44

What is the latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Fixed Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 0.45 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.45
Mar20230.45
Mar20220.44
Mar20170.47
Mar20160.44

How is Fixed Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.45
0.00
Mar2023 0.45
2.27
Mar2022 0.44
-6.38
Mar2017 0.47
6.82
Mar2016 0.44 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Fixed Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,616.8 Cr 1.5% -4.1% -17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹379,191.0 Cr 1% -0.9% -13% Stock Analytics
DIVIS LABORATORIES ₹159,973.0 Cr -1.6% -1.8% 17.9% Stock Analytics
CIPLA ₹124,507.0 Cr -1.8% 3.7% -6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,175.0 Cr 0.7% 2.4% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,355.0 Cr -0.6% 4.5% -6.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

1.5%

-4.1%

-17.9%

SENSEX

0.5%

0.1%

-2.1%


You may also like the below Video Courses